These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32928845)

  • 1. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).
    Slater N; White S; Frisher M
    BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
    Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
    Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
    Gerlach LB; Olfson M; Kales HC; Maust DT
    J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA).
    Slater N; White S; Venables R; Frisher M
    BMJ Open; 2018 Mar; 8(3):e020270. PubMed ID: 29540422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
    Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
    JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
    Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
    BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
    Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
    Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing.
    Huang YT; Steptoe A; Wei L; Zaninotto P
    BMC Med; 2021 Dec; 19(1):321. PubMed ID: 34911547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
    O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
    BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication taking in a national sample of dependent older people.
    Ferguson CA; Thomson WM; Smith MB; Kerse N; Peri K; Gribben B
    Res Social Adm Pharm; 2020 Mar; 16(3):299-307. PubMed ID: 31130437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy is a risk factor for hospital admission due to a fall: evidence from the English Longitudinal Study of Ageing.
    Zaninotto P; Huang YT; Di Gessa G; Abell J; Lassale C; Steptoe A
    BMC Public Health; 2020 Nov; 20(1):1804. PubMed ID: 33243195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially inappropriate medicines in a cohort of community-dwelling older people in New Zealand.
    Nishtala PS; Bagge ML; Campbell AJ; Tordoff JM
    Geriatr Gerontol Int; 2014 Jan; 14(1):89-93. PubMed ID: 23530567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially suboptimal prescribing of medicines for older Aboriginal Australians in remote areas.
    Page A; Hyde Z; Smith K; Etherton-Beer C; Atkinson DN; Flicker L; Skeaf L; Malay R; LoGiudice DC
    Med J Aust; 2019 Aug; 211(3):119-125. PubMed ID: 31187902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
    Davies LE; Kingston A; Todd A; Hanratty B
    PLoS One; 2021; 16(1):e0245648. PubMed ID: 33465141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.
    Lee GB; Etherton-Beer C; Hosking SM; Pasco JA; Page AT
    Ther Adv Drug Saf; 2022; 13():20420986221100117. PubMed ID: 35814333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.
    Kotlinska-Lemieszek A; Paulsen O; Kaasa S; Klepstad P
    J Pain Symptom Manage; 2014 Dec; 48(6):1145-59. PubMed ID: 24780183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of Outpatient Use of Medicines by the Elderly Population in Portugal: A Cross-Sectional Study].
    Carmona Araújo A; Fernandes E; Franco Ruivo I; Machado MDC; Faria Vaz A; Furtado C
    Acta Med Port; 2023 Dec; 36(12):792-801. PubMed ID: 37421145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are payment methods for prescription drugs associated with polypharmacy in older adults in Ireland? Evidence from the TILDA cohort study.
    Varley A; Cullinan J
    BMJ Open; 2020 Oct; 10(10):e036591. PubMed ID: 33004388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.